PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 6, 2026Advanced Materials0 citations

Puncture‐Needle‐Integrated Optical Fibers and NIR‐II‐Activated Thermosensitive Hydrogels for Deep‐Seated Tumor Therapy

View Full Paper
BZBin ZhangWPWen PangHBHua Bai

Key Points

  • The aim is to develop a drug-device platform for effective treatment of deep-seated tumors.
  • Designed a puncture-needle-integrated platform combining optical fibers and thermosensitive hydrogels.
  • Utilized a spherical-tip polymer optical fiber to deliver near-infrared II light.
  • Developed an injectable hydrogel for localized photothermal agent delivery.
  • Achieved a 90% tumor regression rate in mice models.
  • Demonstrated superior treatment efficacy compared to traditional methods with enhanced heating uniformity.
  • Showed reduced systemic toxicity and off-target damage during treatment.

Abstract

ABSTRACT Deep‐seated tumors are difficult to treat because of their location, conventional treatment resistance, and limited light penetration during photothermal therapy (PTT). Interstitial PTT with “inside‐out” laser irradiation using optical fibers (OFs) offers a promising solution. This study proposes a drug‐device integrated platform assisted by a puncture needle combining stimuli‐responsive hydrogels with a spherical‐tip polymer OF ( SPOF ) to overcome dual challenges: Inadequate photothermal agent retention and insufficient optical penetration. The injectable thermosensitive hydrogel ( SW8@Gel ), composed of Pluronic F127 and aza‐boron‐dipyrromethene‐derived SW8 nanoparticles, rapidly undergoes sol–gel transition at 38°C, facilitating localized and sustained delivery of the photothermal agent. The flexible low‐bending‐loss SPOF emits 360° divergent near‐infrared II (1064 nm) light from its spherical tip, allowing single‐fiber illumination of deep‐seated tumors (penetration >10 cm) in complex biological environments. Integrating these components enables depth‐adaptive tumor ablation. Compared to other methods, the SPOF / SW8@Gel combination demonstrates the lowest frequency and shortest duration for PTT of deep‐seated tumors and achieves superior efficacy, with a 90% tumor regression rate in mice models and no off‐target damage due to enhanced heating uniformity and reduced systemic toxicity. This platform offers a transformative clinically viable solution for precise ablation of deep malignancies, bridging advanced photonics and targeted oncotherapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/698585fe8f7c464f23009cf2https://doi.org/10.1002/adma.202517632
Ask AI
Helpful
Bookmark
Share
View Full Paper